Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019407
Filing Date
2024-05-15
Accepted
2024-05-15 06:22:08
Documents
42
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 500652
2 ex31-1.htm EX-31.1 8038
3 ex31-2.htm EX-31.2 8026
4 ex32-1.htm EX-32.1 4850
5 ex32-2.htm EX-32.2 4869
  Complete submission text file 0001493152-24-019407.txt   2911811

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ladx-20240331.xsd EX-101.SCH 22727
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ladx-20240331_cal.xml EX-101.CAL 27728
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ladx-20240331_def.xml EX-101.DEF 125197
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ladx-20240331_lab.xml EX-101.LAB 214547
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ladx-20240331_pre.xml EX-101.PRE 166038
45 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 344076
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
LadRx Corp (Filer) CIK: 0000799698 (see all company filings)

EIN.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15327 | Film No.: 24946984
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)